familial hypercholesterolemia
 news alert

The PCSK9 Forum:
An exciting new initiative

Established by leading researchers as a not-for-profit organisation, the  PCSK9 Education and Research Forum will provide healthcare professionals with open access to electronic and multimedia platforms providing real-time reporting of significant developments and news; authoritative analysis and commentary; and, an extensive library of accredited educational materials tailored to the differing needs of a spectrum of audiences. As a result, the Forum will expand awareness and knowledge of the significant role played by PCSK9 in lipid metabolism and its value as a novel therapeutic target.

Katherine Wilemon, Founder, President and CEO of the FH Foundation, is on the Editorial Advisory Board of this fast growing network, whose goal is to become a major, globally-recognised source of independent, scientific knowledge of the critical importance of PCSK9 inhibition in the search for treatments which promise to transform the prognosis of millions of people with atherosclerotic dyslipidaemia.

You can sign up for important news and updates in the works of PCSK9 here: 

Stay Connected
Like us on Facebook    Follow us on Twitter    View our profile on LinkedIn    Find us on Google+